Using our document store

How to use our document store

To use our Documents store, please follow these instructions:

1. Click on the red arrow next to the folder name to find the folder you are looking for.

2. Click on the folder's name to view the documents within that folder at the bottom of the page.  Please note only ten documents are shown at a time, so you may need to click 'next' to find the right document.

Media browser

Format Status Title Description Size Download
xlsx Current High cost drugs reimbursement arrangements December 2018 PbR excluded high cost drug reimbursement list 2018/19 Southampton City CCG North Hampshire CCG West Hampshire CCGAbatacept Adalimumab Adalimumab Adalimumab Adalimumab Adalimumab Adalimumab Aflibercept Aflibercept Aflibercept Alirocumab Alitretinoin Amikacin inhalation Anakinra Apremilast Apremilast Apremilast Baricitinib Bevacizumab Bevacizumab Botulinum Toxin Brodalumab Cenegermin Certolizumab Pegol Certolizumab Pegol Certolizumab Pegol Certolizumab Pegol Ciprofloxacin inhalation Cladribine Collagenase clostridium histolyticum Collagenase Dexamethasone (intravitreal implant) Dexamethasone (intravitreal implant) Digoxin-specific antibody fragments Dupilumab Eltrombopag Eptotermin alpha Etanercept Etanercept Etanercept Etanercept Etanercept Evolocumab Fluocinolone acetonide (intravitreal implant) Fomepizole Glucarpidase Golimumab Golimumab Golimumab Golimumab Golimumab Guselkumab Iloprost Infliximab Infliximab Infliximab Infliximab Infliximab Infliximab Ixekizumab Ixekizumab Ixekizumab Ocrelizumab Ocriplasmin Omalizumab Parenteral Nutrition Pegaptanib Ranibizumab Ranibizumab Ranibizumab Ranibizumab Riluzole Rituximab Rituximab Romiplostim Secukinumab Secukinumab Sodium oxybate Somatropin Somatropin Teriparatide Tocilizumab Toclizumab Tolvaptan Tolvaptan Ustekinumab Vedolizumab Verteporfin 57KB Download
pdf Current High cost drugs reimbursement arrangements summary North Hampshire, Southampton City and West Hampshire CCGs 18/19 - December 2018 West Hampshire Southampton City North Hampshire CCG Payment by results excluded high cost drugs reimbursement arrangements 2018/19 summary Allergen immunotherapy Antibacterial Drugs Blood-related products Bone metabolism (drugs affecting) Bone morphogenic protein Omalizumab Guselkumab Ixekizumab Ocrelizumab Amikacin inhalation Ciprofloxacin inhalation ADMINISTRATION VIA ROUTES OTHER THAN INHALATION OR NEBULISATION INCLUDED IN TARIFF Dried prothrombin complex- for emergency anticoagulant reversal Teriparatide Eptotermin alpha (Osigraft®) Cytokine modulators Enzymes Growth hormone and growth hormone receptor antagonists Abatacept Adalimumab Anakinra Apremilast Brodalumab Certolizumab pegol Etanercept Golimumab Infliximab Rituximab (non-chemotherapy) Sarilumab Tocilizumab Ustekinumab Secukinumab Vedolizumab Collagenase clostridium histolyticum Somatropin Cenegermin Tolvaptan Hypnotics & anxiolytics Lipid regulating drugs Macular Oedema Parenteral nutrition Platelet disorder drugs Immunosuppressant Sodium oxybate Alirocumab Evolocumab Dexamethasone intravitreal implant Fluocinolone acetonide intravitreal implant Parenteral nutrition Eltrombopag Romiplostim Baricitinib Poisoning Pulmonary hypertension Skin conditions Fomepizole Digoxin specific antibody fragments Glucarpidase Iloprost Alitretinoin Apremilast Ixekizumab Guselkumab Subfoveal choroidal neovascularisation Torsion dystonias & other involuntary movements Aflibercept Pegaptanib Ranibizumab Verteporfin Bevacizumab (unlicensed) Ocriplasmin Riluzole Botulinum toxin types A and B 174KB Download